ERBB2 and breast cancer: In contrast, regulatory T cell infiltration is predominant in ER + and HER2 + breast cancer tissues and is not associated with patient prognosis.[14] Exploring the infiltration of immune cells in breast cancer can provide clues for explaining the mechanism of interaction between tumor and immune cells and finding new targets for immunological therapy.